APA

Kiyohara E., Tanemura A., Nishioka M., Yamada M., Tanaka A., Yokomi A., Saito A., Sakura K., Nakajima T., Myoui A., Sakurai T., Kawakami Y., Kaneda Y. & Katayama I. (20200603). Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study. : Cancer immunology, immunotherapy : CII.

Chicago

Kiyohara Eiji, Tanemura Atsushi, Nishioka Megumi, Yamada Mizuho, Tanaka Aya, Yokomi Akinori, Saito Atsuhiro, Sakura Kazuma, Nakajima Toshihiro, Myoui Akira, Sakurai Toshiharu, Kawakami Yutaka, Kaneda Yasufumi and Katayama Ichiro. 20200603. Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study. : Cancer immunology, immunotherapy : CII.

Harvard

Kiyohara E., Tanemura A., Nishioka M., Yamada M., Tanaka A., Yokomi A., Saito A., Sakura K., Nakajima T., Myoui A., Sakurai T., Kawakami Y., Kaneda Y. and Katayama I. (20200603). Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study. : Cancer immunology, immunotherapy : CII.

MLA

Kiyohara Eiji, Tanemura Atsushi, Nishioka Megumi, Yamada Mizuho, Tanaka Aya, Yokomi Akinori, Saito Atsuhiro, Sakura Kazuma, Nakajima Toshihiro, Myoui Akira, Sakurai Toshiharu, Kawakami Yutaka, Kaneda Yasufumi and Katayama Ichiro. Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study. : Cancer immunology, immunotherapy : CII. 20200603.